XS-03

Metastatic Colorectal Cancer With RAS Mutation

NovaOnco Therapeutics Co., Ltd.Phase 1/2

—

Rating in progress

XS-03 in Metastatic Colorectal Cancer With RAS Mutation is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.

Methodology v0.2 · Active